1.20 0.05(4.35%)05/20/2024
Akebia Therapeutics Inc. (AKBA)
Akebia Therapeutics Inc. (AKBA)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Akebia Therapeutics to Present at the 2nd Annual HCW Bioconnect Investor Conference | 05/14 08:00 | prnewswire.com |
| Akebia Therapeutics, Inc. (AKBA) Q1 2024 Earnings Call Transcript | 05/09 10:54 | seekingalpha.com |
| Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates | 05/09 09:10 | zacks.com |
| Akebia Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights | 05/09 07:00 | prnewswire.com |
| Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights | 05/02 08:30 | prnewswire.com |
| Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 05/01 16:05 | prnewswire.com |
| Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management | 04/04 17:56 | seekingalpha.com |
| Akebia Therapeutics Surges on FDA Approval for Anemia Treatment | 04/03 09:11 | marketbeat.com |
| Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD | 03/28 08:11 | zacks.com |